ODE Division Director Ulatowski Appointed Office Of Compliance Chief
This article was originally published in The Gray Sheet
Executive Summary
Center for Devices & Radiological Health veteran Timothy Ulatowski will assume the position of Office of Compliance director starting Jan. 22, pending final sign-off by FDA Commissioner Mark McClellan
You may also be interested in...
OC FY 2005 Priorities: MDUFMA, Bioterror, Closing Out Enforcement Actions
Fiscal 2005 marks the inaugural year for the CDRH Office of Compliance's new inspection planning process, an initiative that reflects FDA's emphasis on risk-based regulation
OC FY 2005 Priorities: MDUFMA, Bioterror, Closing Out Enforcement Actions
Fiscal 2005 marks the inaugural year for the CDRH Office of Compliance's new inspection planning process, an initiative that reflects FDA's emphasis on risk-based regulation
FDA Stresses Early Discussion Of Foreign Data In Post-MDUFMA World
CDRH is urging sponsors to schedule pre-filing meetings with the device center, especially if firms plan to use data collected in trials conducted outside the U.S